Cellsonics
Biotechnology company developing SimpleFlow™ technology - the first fully automated tissue dissociation workflow from solid tissue to single cells while maintaining native gene expression.
Website
https://cellsonics.comLocation
Netherlands
Founded
2021
Investors
1
Categories
single-cell, tissue-dissociation, genomics, biotech, lab-automation
Notes
Cellsonics is a biotechnology company developing proprietary SimpleFlow™ technology to enable the first fully automated tissue dissociation workflow from solid tissue to single cells. Their technology maintains native gene expression during the dissociation process, addressing a critical challenge in single-cell genomics and research.
The company's automated workflow reduces variability and improves reproducibility in single-cell analysis, making it easier for researchers to obtain high-quality single-cell data from tissue samples.
Team
- Johan van der Vlag, Ph.D. - Co-founder & Chief Executive Officer
- LinkedIn: linkedin.com/in/johanvandervlag
Additional Research Findings
- SimpleFlow™ automated tissue dissociation technology
- Focus on maintaining native gene expression
- Enables reproducible single-cell analysis from tissue
- Laboratory automation for single-cell genomics
- Based in the Netherlands
- Serving research and pharmaceutical markets
Sources
Investors
| Name | Location | Type | Stages | Portfolio |
|---|---|---|---|---|
| OMX Ventures | San Francisco, California, USA | biotech-focused | seedseries-a | 23 |